IBDEI1XK ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33911,1,4,0)
 ;;=4^I69.820
 ;;^UTILITY(U,$J,358.3,33911,2)
 ;;=^5007522
 ;;^UTILITY(U,$J,358.3,33912,0)
 ;;=I69.220^^183^2013^6
 ;;^UTILITY(U,$J,358.3,33912,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33912,1,3,0)
 ;;=3^Aphasia following other nontraumatic intracranial hemorrhage
 ;;^UTILITY(U,$J,358.3,33912,1,4,0)
 ;;=4^I69.220
 ;;^UTILITY(U,$J,358.3,33912,2)
 ;;=^5007459
 ;;^UTILITY(U,$J,358.3,33913,0)
 ;;=I69.290^^183^2013^11
 ;;^UTILITY(U,$J,358.3,33913,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33913,1,3,0)
 ;;=3^Apraxia following other nontraumatic intracranial hemorrhage
 ;;^UTILITY(U,$J,358.3,33913,1,4,0)
 ;;=4^I69.290
 ;;^UTILITY(U,$J,358.3,33913,2)
 ;;=^5007484
 ;;^UTILITY(U,$J,358.3,33914,0)
 ;;=I69.390^^183^2013^7
 ;;^UTILITY(U,$J,358.3,33914,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33914,1,3,0)
 ;;=3^Apraxia following cerebral infarction
 ;;^UTILITY(U,$J,358.3,33914,1,4,0)
 ;;=4^I69.390
 ;;^UTILITY(U,$J,358.3,33914,2)
 ;;=^5007515
 ;;^UTILITY(U,$J,358.3,33915,0)
 ;;=I69.190^^183^2013^8
 ;;^UTILITY(U,$J,358.3,33915,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33915,1,3,0)
 ;;=3^Apraxia following nontraumatic intracerebral hemorrhage
 ;;^UTILITY(U,$J,358.3,33915,1,4,0)
 ;;=4^I69.190
 ;;^UTILITY(U,$J,358.3,33915,2)
 ;;=^5007452
 ;;^UTILITY(U,$J,358.3,33916,0)
 ;;=I69.090^^183^2013^9
 ;;^UTILITY(U,$J,358.3,33916,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33916,1,3,0)
 ;;=3^Apraxia following nontraumatic subarachnoid hemorrhage
 ;;^UTILITY(U,$J,358.3,33916,1,4,0)
 ;;=4^I69.090
 ;;^UTILITY(U,$J,358.3,33916,2)
 ;;=^5007420
 ;;^UTILITY(U,$J,358.3,33917,0)
 ;;=I69.890^^183^2013^10
 ;;^UTILITY(U,$J,358.3,33917,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33917,1,3,0)
 ;;=3^Apraxia following other cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,33917,1,4,0)
 ;;=4^I69.890
 ;;^UTILITY(U,$J,358.3,33917,2)
 ;;=^5007546
 ;;^UTILITY(U,$J,358.3,33918,0)
 ;;=I69.393^^183^2013^12
 ;;^UTILITY(U,$J,358.3,33918,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33918,1,3,0)
 ;;=3^Ataxia following cerebral infarction
 ;;^UTILITY(U,$J,358.3,33918,1,4,0)
 ;;=4^I69.393
 ;;^UTILITY(U,$J,358.3,33918,2)
 ;;=^5007518
 ;;^UTILITY(U,$J,358.3,33919,0)
 ;;=I69.193^^183^2013^13
 ;;^UTILITY(U,$J,358.3,33919,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33919,1,3,0)
 ;;=3^Ataxia following nontraumatic intracerebral hemorrhage
 ;;^UTILITY(U,$J,358.3,33919,1,4,0)
 ;;=4^I69.193
 ;;^UTILITY(U,$J,358.3,33919,2)
 ;;=^5007455
 ;;^UTILITY(U,$J,358.3,33920,0)
 ;;=I69.293^^183^2013^16
 ;;^UTILITY(U,$J,358.3,33920,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33920,1,3,0)
 ;;=3^Ataxia following other nontraumatic intracranial hemorrhage
 ;;^UTILITY(U,$J,358.3,33920,1,4,0)
 ;;=4^I69.293
 ;;^UTILITY(U,$J,358.3,33920,2)
 ;;=^5007487
 ;;^UTILITY(U,$J,358.3,33921,0)
 ;;=I69.093^^183^2013^14
 ;;^UTILITY(U,$J,358.3,33921,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33921,1,3,0)
 ;;=3^Ataxia following nontraumatic subarachnoid hemorrhage
 ;;^UTILITY(U,$J,358.3,33921,1,4,0)
 ;;=4^I69.093
 ;;^UTILITY(U,$J,358.3,33921,2)
 ;;=^5007423
 ;;^UTILITY(U,$J,358.3,33922,0)
 ;;=I69.893^^183^2013^15
 ;;^UTILITY(U,$J,358.3,33922,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33922,1,3,0)
 ;;=3^Ataxia following other cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,33922,1,4,0)
 ;;=4^I69.893
 ;;^UTILITY(U,$J,358.3,33922,2)
 ;;=^5007549
 ;;^UTILITY(U,$J,358.3,33923,0)
 ;;=I69.31^^183^2013^17
 ;;^UTILITY(U,$J,358.3,33923,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33923,1,3,0)
 ;;=3^Cognitive deficits following cerebral infarction
 ;;
 ;;$END ROU IBDEI1XK
